A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden

NCT02077946 · Completed

Last updated 2026-05-28

This study looked back at medical records to see how well liraglutide worked in lowering blood sugar levels in adults with type 2 diabetes treated in Swedish primary care clinics.

Status Completed The study has finished.

Type Observational

Participants 1,059 people

Who can join Ages 18+ · all sexes

Timeline Started 2014-02 · est. completion 2014-09

Where 1 site · Sweden

What this study is testing ClinicalTrials.gov NCT02077946 ↗

Description as written by the study sponsor.

This trial is conducted in Europe. The aim of this study is to investigate a retrospective database assessment of clinical effectiveness in type 2 diabetes patients treated with liraglutide from primary care centers in Sweden.

Treatments tested

liraglutide Drug

No treatment given.
sitagliptin Drug

No treatment given.

Main thing measured	Percent (%) of patients achieving at least 1 %-point HbA1c (glycosylated haemoglobin) reduction
Sponsor	Novo Nordisk A/S
Conditions studied	Diabetes, Diabetes Mellitus, Type 2
GLP-1 drugs	liraglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT02077946 ↗